Business intelligence for the animal health industries
Animal Pharm Reports
Essential business, market and company information
Biotechnology
Avian 'Flu: The role of animal health companies in its control and eradication
Published: 31/01/2006

This report investigates the technical background to avian flu, and details the range of identification, control and eradication strategies that are available. It identifies the potential role of animal health companies in these efforts, specifically with respect to diagnostics and vaccines, and discusses these sectors in terms of their strengths and weaknesses, and key R&D objectives to improve their effectiveness.
Veterinary Vaccines
Published: 31/08/2005

The veterinary vaccines sector accounted for 20% of global animal health product revenues in 2004. Global sales totalled $3.2 billion and the latest market forecasts predict the sector will grow in excess of $4 billion by 2009. This report examines the market forces within this commercially important sector, highlighting key market drivers and providing a detailed analysis of future growth.
Antibacterials in the Animal Health Industry
Published: 05/04/2005

Global sales of animal health antibiotics are forecast to reach $4.65 billion by 2010. This Animal Pharm report analyses all the major commercial issues affecting this market.
Biotechnology, Cloning and Genetics: A revolution in the animal health industry?
Published: 09/02/2004

Recent advances in biotechnology, cloning and genetics have made possible a wide range of new technologies and products. Over the next decade these may revolutionise both commercial livestock production and the companion animal sector. This Animal Pharm report is the first to identify the commercial potential of these new technologies.
Immunodiagnostics and Nucleic Acid Testing Kits for the Veterinary Industry: Current status and future prospects
Published: 09/12/2003

The market for immunodiagnostics and nucleic acid testing (NAT) was worth $440 million in 2002 and is forecast to grow to $587 million by 2008, when companion animal products will account for two thirds of sales. This Animal Pharm report will provide you with essential technical, managerial and market information to improve your business performance.
Salmonella: Market opportunities for the animal health industry
Published:11/06/2003

Salmonella is a major issue for all stakeholders in the food chain. Its control represents a significant market for animal health companies that manufacture antimicrobials, vaccines and diagnostic tools. 423 million of Salmonella control products were sold in 2002, and this figure is forecast to rise to $669 million by 2007. The largest growth area will be vaccines, sales of which should see an eight-fold increase over the next five years. Salmonella: Market opportunities for the animal health industry analyses all aspects of this dynamic market, which is being driven by new product development and increasingly stringent legislation.